TickerFacts.

Idexx Laboratories Inc (IDXX): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 2-for-1, first reflected in a filing dated 2015-07-30. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

$13.08
Year ended 2025-12-31
+17.7%
3-year compound annual growth
+14.3%
5-year compound annual growth
+20.4%
10-year compound annual growth
2008-12-31: $1.872009-12-31: $2.012010-12-31: $2.372011-12-31: $2.782012-12-31: $3.172013-12-31: $1.742014-12-31: $1.792015-12-31: $2.052016-12-31: $2.442017-12-31: $2.942018-12-31: $4.262019-12-31: $4.892020-12-31: $6.712021-12-31: $8.602022-12-31: $8.032023-12-31: $10.062024-12-31: $10.672025-12-31: $13.08$13.08
2008-12-31 EPS (Diluted) (USD per share) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$13.08+22.6%2026-02-20, From 2025-01-01
2024-12-31$10.67+6.1%2026-02-20, From 2024-01-01
2023-12-31$10.06+25.3%2026-02-20, From 2023-01-01
2022-12-31$8.03-6.6%2025-02-21, From 2022-01-01
2021-12-31$8.60+28.2%2024-02-22, From 2021-01-01
2020-12-31$6.71+37.2%2023-02-16, From 2020-01-01
2019-12-31$4.89+14.8%2022-02-16, From 2019-01-01
2018-12-31$4.26+44.9%2021-02-12, From 2018-01-01
2017-12-31$2.94+20.5%2020-02-14, From 2017-01-01
2016-12-31$2.44+19.0%2019-02-15, From 2016-01-01
2015-12-31$2.05+14.5%2018-02-16, From 2015-01-01
2014-12-31$1.79+2.9%2017-02-17, From 2014-01-01
2013-12-31$1.74n/c2016-02-17, From 2013-01-01
2012-12-31$3.17+14.0%2015-02-17, From 2012-01-01
2011-12-31$2.78+17.3%2014-02-18, From 2011-01-01
2010-12-31$2.37+17.9%2013-02-19, From 2010-01-01
2009-12-31$2.01+7.5%2012-02-17, From 2009-01-01
2008-12-31$1.87n/a2011-02-22, From 2008-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Idexx Laboratories Inc (IDXX)2025-12-31$13.08+22.6%
QuidelOrtho Corp (QDEL)2025-12-28-$16.69n/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$3.41-21.8%
Neogen Corp (NEOG)2026-05-31-$0.04n/m
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗